https://burns-media.com/biotech/ en-us © 2026 Burns Media Daily biotech catalyst briefing for investors and analysts allocating against FDA decisions. PDUFA dates, AdCom votes, Phase 2/3 readouts, deal tape. Signal over hype. Every weekday morning. Daily biotech catalyst briefing for investors and analysts allocating against FDA decisions. PDUFA dates, AdCom votes, Phase 2/3 readouts, deal tape. Signal over hype. Every weekday morning. The catalyst calendar for biotech investors. Burns Media Burns Media podcast@burns-media.com false episodic Sat, 18 Apr 2026 20:48:11 +0000 https://burns-media.com/assets/social/biotech-podcast.png https://burns-media.com/biotech/ https://burns-media.com/biotech/archive/2026-04-18 https://burns-media.com/audio/biotech/2026-04-18.mp3 Sat, 18 Apr 2026 07:00:00 +0000 UCB's acquisition diversifies its epilepsy treatment portfolio amid rising competition. 02:21 false full